A Small Molecule Ligand of the Glucagon-like Peptide 1 Receptor Targets Its Amino-terminal Hormone Binding Domain (original) (raw)
New perspectives on the use of glucagon-like peptide 1 in diseases of the central nervous system
Małgorzata Łupina
Current Issues in Pharmacy and Medical Sciences, 2023
View PDFchevron_right
Allosteric Ligands of the Glucagon-Like Peptide 1 Receptor (GLP-1R) Differentially Modulate Endogenous and Exogenous Peptide Responses in a Pathway-Selective Manner: Implications for Drug Screening
Roger Summers
Molecular Pharmacology, 2010
View PDFchevron_right
Glucagon-like peptide-1(7–36) amide is a new incretin/enterogastrone candidate
Burkhard Göke
European Journal of Clinical Investigation, 1991
View PDFchevron_right
Weight Loss and Maintenance Related to the Mechanism of Action of Glucagon-Like Peptide 1 Receptor Agonists
angela fitch
Advances in Therapy, 2021
View PDFchevron_right
Glucagon-like peptide 1 receptor agonists and dipeptidyl peptidase IV inhibitors: new therapeutic agents for the treatment of type 2 diabetes
Mo Khan
Current Opinion in Endocrinology & Diabetes, 2005
View PDFchevron_right
Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans
Burkhard Göke
Gut, 2006
View PDFchevron_right
Long-Term Inhibition of the Glucagon Receptor with a Monoclonal Antibody in Mice Causes Sustained Improvement in Glycemic Control, with Reversible -Cell Hyperplasia and Hyperglucagonemia
Murielle Veniant
Journal of Pharmacology and Experimental Therapeutics, 2009
View PDFchevron_right
Immunocytochemical Study of Peptide Receptors
David Berlove
Annals of the New York Academy of Sciences, 1990
View PDFchevron_right
Glucagon-like peptide-1 derivatives and dipeptidyl peptidase-IV inhibitors. New hope for the treatment of type-2 diabetes
Mohamed Al-Omar
Saudi Medical Journal, 2005
View PDFchevron_right
Insulin-like peptide 5 is an orexigenic gastrointestinal hormone
Johannes Grosse
2014
View PDFchevron_right
A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents
Sabine Uhles
Nature Medicine, 2014
View PDFchevron_right
G protein-coupled receptors and obesity
Alessandro Pocai
Frontiers in Endocrinology, 2023
View PDFchevron_right
Role of Fat Hydrolysis in Regulating Glucagon-Like Peptide-1 Secretion
Burkhard Göke
The Journal of Clinical Endocrinology & Metabolism, 2010
View PDFchevron_right
Pharmacological Targeting of Glucagon and Glucagon-Like Peptide 1 Receptors Has Different Effects on Energy State and Glucose Homeostasis in Diet-Induced Obese Mice
Murielle Veniant
Journal of Pharmacology and Experimental Therapeutics, 2011
View PDFchevron_right
Different domains of the glucagon and glucagon-like peptide-1 receptors provide the critical determinants of ligand selectivity
Birgitte Wulff
British Journal of Pharmacology, 2003
View PDFchevron_right
Crosstalk between diabetes and brain: Glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration
Paula Moreira
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013
View PDFchevron_right
A Peptide Derived from a β2-Adrenergic Receptor Transmembrane Domain Inhibits Both Receptor Dimerization and Activation
Daniel-g Bichet
Journal of Biological Chemistry, 1996
View PDFchevron_right
Protein and Peptide in Drug Targeting and its Therapeutic Approach
Dr. RAJ KUMAR KESERVANI
Ars Pharmaceutica (Internet), 2015
View PDFchevron_right
A model for receptor-peptide binding at the glucagon-like peptide-1 (GLP-1) receptor through the analysis of truncated ligands and receptors
Suleiman al-Sabah, Dan Donnelly
British Journal of Pharmacology, 2003
View PDFchevron_right
Adaptive infusion of a glucagon‐like peptide‐1/glucagon receptor co‐agonist G3215, in adults with overweight or obesity: Results from a phase 1 randomized clinical trial
SALEEM ANSARI
Diabetes, Obesity and Metabolism, 2024
View PDFchevron_right
Development of brain insulin receptors
William Lowe
International Journal of Biochemistry, 1988
View PDFchevron_right
Glucagon and Glucagon-Like Peptide Receptors as Drug Targets
Jennifer Estall
Current Pharmaceutical Design, 2006
View PDFchevron_right
Functional analysis of the purified glucocorticoid receptor
Sam Okret
Journal of Steroid Biochemistry, 1986
View PDFchevron_right
Glucagon-like peptide 1 receptor Product specification
Robben Wainer
View PDFchevron_right
Double-Mutant Cycle Scanning of the Interaction of a Peptide Ligand and Its G Protein-Coupled Receptor †
Fred Naider
Biochemistry, 2007
View PDFchevron_right